Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Supplement—May 2025

SUPPLEMENT ISSUE
Supplement

Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA

Laura Marcela Torres1Comments to Author , Jared Johnson1, Audrey Valentine1, Audrey Brezak, Emily C. Schneider, Marisa D’Angeli, Jennifer Morgan, Claire Brostrom-Smith, Chi N. Hua, Michael Tran, Darren Lucas, Joenice Gonzalez De Leon, Drew MacKellar, Philip Dykema, Kelly J. Kauber, and Allison Black
Author affiliation: Washington State Department of Health, Shoreline, Washington, USA (L.M. Torres, J. Johnson, A. Valentine, A. Brezak, E.C. Schneider, M. D’Angeli, C.N. Hua, M. Tran, D. Lucas, J. Gonzalez De Leon, D. Mackellar, P. Dykema, K.J. Kauber, A. Black); Public Health Seattle and King County, Seattle, Washington, USA (J. Morgan, C. Brostrom-Smith)

Main Article

Figure 2

Timeline showing overlap of patients with Klebsiella pneumoniae carbapenemase–producing K. pneumoniae infection in healthcare facilities in Washington, USA, as part of study of integrating genomic data into public health surveillance for multidrug-resistant organisms. PTs A, B, and C stayed in HF I. PT A might have overlapped with PT C in HF I in 2023; PT B stayed in HF I in 2021. PTs B and C both stayed in HF II but at different times, in 2022 and in 2023. PT D stayed at HF III in 2021, where an overlap with PT B might have occurred, and in 2022, PT D might have overlapped with PT A in HF IV. PTs E and F who had stayed in HF V could also be related to this outbreak. HF, health facility; PT, patient.

Figure 2. Timeline showing overlap of patients with Klebsiella pneumoniae carbapenemase–producing K. pneumoniae infection in healthcare facilities in Washington, USA, as part of study of integrating genomic data into public health surveillance for multidrug-resistant organisms. PTs A, B, and C stayed in HF I. PT A might have overlapped with PT C in HF I in 2023; PT B stayed in HF I in 2021. PTs B and C both stayed in HF II but at different times, in 2022 and in 2023. PT D stayed at HF III in 2021, where an overlap with PT B might have occurred, and in 2022, PT D might have overlapped with PT A in HF IV. PTs E and F who had stayed in HF V could also be related to this outbreak. HF, health facility; PT, patient.

Main Article

1These first authors contributed equally to this article.

Page created: March 06, 2025
Page updated: May 12, 2025
Page reviewed: May 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external